(MM) (NASDAQ:LCAV)
Historical Stock Chart
From Jul 2019 to Jul 2024
LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision
correction services under the LasikPlus brand, announced today
that it has implemented Bausch & Lomb’s
Zyoptix 100 Hz and Advanced Personalized Technologies at its LasikPlus
vision centers across the country. These technologies from Bausch & Lomb
combine the benefits of a faster treatment with some of the latest
research in the industry. The Advanced Personalized Technology enables
the surgeon to uniquely tailor laser vision correction therapy to a
patient’s individualized needs and customize
the critical part of the treatment area, known as the optical zone, to
each patient’s pupil size.
“We continue to invest in leading technology
that optimizes patient outcomes and satisfaction. Our evaluation of the
Zyoptix 100Hz and Advanced Personalized Technologies met the
expectations of our Medical Advisory Board, surgeons, vision center
staff, and our patients,” said Steve Straus,
LCA Vision’s Chief Executive Officer.
Forward-Looking Statements
This news release may contain forward-looking statements that are
subject to risks and uncertainties that may result in actual results to
differ materially from current expectations. For a discussion of risks
and uncertainties faced, please refer to our filings with the Securities
and Exchange Commission including, but not limited to, our Forms 10-K
and 10-Q.
About LCA-Vision Inc./LasikPlus
LCA-Vision Inc., a leading provider of laser vision correction services
under the LasikPlus brand, operates 72 LasikPlus
fixed-site laser vision correction centers in 32 states and 56 markets
in the United States and a joint venture in Canada. Additional company
information is available at www.lca-vision.com
and www.lasikplus.com. It's
Not Just LASIK. It's LasikPlus!